This clinical practice guideline was produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use of public funds. This project…
This background document outlines the methods used to develop the Criteria for the Clinical Use of Immune Globulin, which was produced as part of the Prairie Collaborative Immune Globulin Utilization Management Framework project. The Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project was initiated to establish criteria for IG therapy as a means…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle…